Description

Taking place on the 8-9th March 2017 in partnership with the Innovation Forum and NIHR, and developed by a cohort of thought leaders at J&J and Lilly this year’s congress marks the 10th anniversary of the world series.

The Clinical Innovation and Partnering Congress will be showcasing disruptive tech, game-changing innovation, novel partnering strategies to deliver clinical trials of the future with patient centricity at its heart.

Topics that will be covered include:

• M-Health and wearables
• Patient-centric clinical trials
• Opportunities for clinical innovation.
• Relationship management
• Outsourcing strategies
• How to future proof your clinical operations.
• Trials and tribulations

Selected speakers:

• Eric Low, Chief Executive Officer, Myeloma U.K.
• Bert Hartog, Director Clinical R and D, R&D Operations - Innovation Leader, Johnson and Johnson
• Yuri Martina, Vice President Clinical Operations, Shionogi Ltd
• Stephen Nabarro, Head of Clinical Operations and Data Management Drug Development Office Strategy and Research Funding, Cancer Research UK
• Jane Rhodes, Senior Director, New Initiatives, Innovation Hub, Biogen
• Marc Sluijs, Digital health investment advisory, Merck

Date: 8-9 March 2017

Time: 08.00 - 17.00

Venue: Hilton Tower Bridge, London, UK

Read more: www.healthnetworkcommunications.com/conference/innovation-and-partnering/